Basic Transfusion Biology
The Basic Transfusion Biology Working Party is focused on promoting experimental design approaches that investigate the molecular and cellular basis of how blood transfusions and related pathologies, and biotherapies, work.
Working Parties
Our Working Parties are topic-driven groups that promote science research and best practice in their areas of expertise across the transfusion chain. As a member of a working party you can actively discuss your work with like-minded colleagues from around the globe, attend working party meetings, have access to the members-only content and join discussions.
Currently, ISBT has a total of 17 Working Parties, some of them work closely together. Each Working Party has a formal committee structure and is coordinated by a Chair or Co-Chairs. To read more information about the Working Parties, click on the Working Party of interest below.
Big Data
Our aim is to advance big data research in transfusion medicine, promote public health use of donor data and samples, and raise awareness of emerging technologies relevant to transfusion biology.
Blood Components
Our aim is to promote best practice, monitor trends and emerging new practices, facilitate improvements and raise awareness of blood component manufacturing and research globally.
Blood supply management
Our aim is to optimise the use of donated blood and blood component wastage along the whole chain.
Cellular Therapies
Our mission is to raise awareness of cellular therapies and support their improvement globally within Transfusion Medicine.
Clinical Transfusion
The aim of this working party is to promote evidence-based clinical transfusion and patient blood management practices by developing educational tools and best practice recommendations, providing expert opinions, and conducting research with a global focus.
Donors and Donation
Our aim is to monitor trends and emerging new practices related to blood donors and donation and facilitate training in resource-limited countries.
Global Blood Safety
Our aim is to foster and support global improvements in blood safety and availability.
Granulocyte Immunobiology
Our aim is to enable collaborations in granulocyte immunobiology by bringing together members working in a (diagnostic) laboratory, research and/or clinical setting.
Haemovigilance
Our aim is to improve safety for blood donors and transfusion recipients through promoting and supporting haemovigilance systems.
Immunohaematology
Our aim is to promote best practice and facilitate improvements in immunohaematology through education, exchange of ideas/resources and support red cell serology, molecular testing, antigen/allele matching and transfusion recommendations.
Information Technology
Our aim is to exchange ideas and information related to Information Technology for use in Transfusion Medicine.
Platelet Immunobiology
Our aim is to enable collaborations in platelet immunobiology by bringing together members working in a (diagnostic) laboratory, research and/or clinical setting.
Quality Management
Our aim is to define quality systems in blood transfusion medicine and to promote education and training in Quality Management
Rare Donors
Our aim is to enhance international collaboration to enable provision of rare blood to patients.
Red Cell Immunogenetics and Blood Group Terminology
Our aim is to develop and maintain guidelines for blood group antigen and allele nomenclature for use in Transfusion Medicine and related sciences.
Transfusion Transmitted Infectious Diseases
Our aim is to evaluate and advance safety of blood transfusion by analysing Transfusion Transmitted Infectious Diseases, coordinating international studies and publishing scientific reports.